昔利【药品类型】抗过敏药 【中文名】昔利 【通用名】盐酸西替利嗪片 【产品英文名】Cetirizine Hydrochloride Tablets 【药品性状】本品为白色或类白色片。 【产品规格】10mg 【药品成分】本品主要成分是盐酸西替利嗪 【孕妇用药】妊娠期及哺乳期妇女禁用。 【贮藏方法】遮光、密封保存。
奥昔利平 Oxyclipine ; Propenzolate
喹那昔利 Quinapril hydrochloride ; Quinapril hydrochl
帕布昔利布 Palbociclib
利妥昔单抗 Rituximab ; Rituxan ; RTX ; MabThera
利福昔明 Rifaximin ; Lifaximin for Suspension
利妥昔单抗注射液 Mabthera ; Rituximab Injection ; Mab ; Ma
英利昔单抗 Remicade ; Infliximab ; Infliximstomair coolingh ; Infliximstomair conditionerh
注射用巴利昔单抗 Basiliximab for Injection ; Basiliximab ; Basiliximab&for
英夫利昔 Infliximab ; IFX
利福昔明片 Rifaximin Tablets ; Rifaximin
这些病人中，通过联合治疗的有69%的人获得缓解而在英夫利昔单抗组中为57%，硫唑嘌呤组中只有28%的到缓解。
Among these patients, 69% achieved remission with the combination treatment compared to 57% of those on Remicade alone and to 28% of those on azathioprine alone.
结果：通过硬化治疗技术，在肠管狭窄区的远端和中间部分注射英夫利昔单抗，全部3名患者的结肠狭窄都得到了扩张。
Results: in all 3 patients, dilation of a colonic stricture was accomplished by injection of infliximab, via the sclerotherapy technique, into the distal and medial portions of the stricture.
经过26周的治疗，联合用药的病人中有57%获得缓解，与之相比，在单用英夫利昔单抗组中只有44%而单用硫唑嘌呤组中只有30%得到缓解。
After 26 weeks of treatment, patients getting the combination had a 57% chance of disease remission, compared to 44% of those getting Remicade alone and to 30% of those getting azathioprine alone.
应用推荐